About Precigen
Precigen is a company based in Germantown (United States) founded in 1998 by Thomas David Reed.. Precigen has raised $233.76 million across 4 funding rounds. The company has 143 employees as of December 31, 2024. Precigen has completed 9 acquisitions, including ActoGeniX, EnviroFlight and Exemplar Genetics. Precigen offers products and services including PRGN-2012, Therapeutic Platforms, and Pipeline Therapies. Precigen operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Biogen, Alnylam and ATAI, among others.
- Headquarter Germantown, United States
- Employees 143 as on 31 Dec, 2024
- Founders Thomas David Reed
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precigen, Inc.
-
Annual Revenue
$3.92 M-36.95as on Dec 31, 2024
-
Net Profit
$-126.23 M-31.63as on Dec 31, 2024
-
EBITDA
$-90.18 M-9.63as on Dec 31, 2024
-
Total Equity Funding
$233.76 M (USD)
in 4 rounds
-
Latest Funding Round
$13 M (USD), Post-IPO
Dec 17, 2020
-
Investors
-
Employee Count
143
as on Dec 31, 2024
-
Investments & Acquisitions
ActoGeniX
& 8 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Precigen
Precigen is a publicly listed company on the NASDAQ with ticker symbol PGEN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Precigen
Precigen offers a comprehensive portfolio of products and services, including PRGN-2012, Therapeutic Platforms, and Pipeline Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Gene therapy for treating recurrent respiratory papillomatosis in adults
Systems for gene expression in immuno-oncology applications
Advancing treatments for autoimmune and infectious diseases
Unlock access to complete
Unlock access to complete
Funding Insights of Precigen
Precigen has successfully raised a total of $233.76M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $13 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $13.0M
-
First Round
First Round
(22 Apr 2011)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Post-IPO - Precigen | Valuation |
investors |
|
| Apr, 2012 | Amount | Series D - Precigen | Valuation |
investors |
|
| Jun, 2011 | Amount | Series D - Precigen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Precigen
Precigen has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include ActoGeniX, EnviroFlight and Exemplar Genetics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Waste is converted into protein-rich agri feedstock using insects.
|
2009 | ||||
|
Genetic miniature pig models are developed for disease research.
|
2008 | ||||
|
Antibody-based therapeutics are developed for biological targets.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Precigen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precigen Comparisons
Competitors of Precigen
Precigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Biogen, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precigen
Frequently Asked Questions about Precigen
When was Precigen founded?
Precigen was founded in 1998 and raised its 1st funding round 13 years after it was founded.
Where is Precigen located?
Precigen is headquartered in Germantown, United States.
Is Precigen a funded company?
Precigen is a funded company, having raised a total of $233.76M across 4 funding rounds to date. The company's 1st funding round was a Series D of $91.83M, raised on Apr 22, 2011.
How many employees does Precigen have?
As of Dec 31, 2024, the latest employee count at Precigen is 143.
What is the annual revenue of Precigen?
Annual revenue of Precigen is $3.92M as on Dec 31, 2024.
What does Precigen do?
Precigen was founded in 1998 and is headquartered in Germantown, United States. Operations center on biopharmaceutical development of gene and cell therapies targeting immuno-oncology, autoimmune disorders, and infectious diseases. A preclinical and clinical pipeline is progressed using non-viral and viral expression systems, along with genome editing, DNA and RNA engineering, and protein bioengineering. Precision technologies are applied to achieve on-target delivery and commercialization potential.
Who are the top competitors of Precigen?
Precigen's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Precigen offer?
Precigen offers PRGN-2012, Therapeutic Platforms, and Pipeline Therapies.
Is Precigen publicly traded?
Yes, Precigen is publicly traded on NASDAQ under the ticker symbol PGEN.
How many acquisitions has Precigen made?
Precigen has made 9 acquisitions, including ActoGeniX, EnviroFlight, and Exemplar Genetics.
What is Precigen's ticker symbol?
The ticker symbol of Precigen is PGEN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.